Lineage Cell Therapeutics In shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 671k | 1.69 |
| 2025-06-30 | $814k | 898k | 0.91 |
| 2025-03-31 | $423k | 937k | 0.45 |
| 2024-12-31 | $205k | 409k | 0.50 |
| 2024-09-30 | $84k | 93k | 0.90 |
| 2023-06-30 | $19k | 13k | 1.44 |
| 2022-09-30 | $55k | 49k | 1.13 |
| 2022-06-30 | $187k | 118k | 1.58 |
| 2022-03-31 | $112k | 73k | 1.54 |
| 2021-03-31 | $188k | 80k | 2.35 |
| 2020-06-30 | $13k | 15k | 0.86 |